Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Category: Psilocybin

Business / Mushrooms / Psilocybin / Psilocybin Derivatives / Research

MindMed – Two Steps Closer to Next Generation Magic Mushroom Formulations

Over the past several months, MindMed has taken two important steps towards the next generation of psychedelic compositions — formulations that harness the Entourage Effect.  First, MindMed recognized the potential …

Business / Patents / Psilocybin / Psilocybin Chemistry

COMPASS Pathways’ $100+ Million Crystalline Form Patent

Compass Pathways Plc. has developed a crystalline form of psilocybin (COMP360) that makes other crystals (like the Hope Diamond, pictured above) look cheap.  Over the last four years, Compass has …

Business / Patents / Psilocybin / Psilocybin Derivatives / Unmet Need

MagicMed – The First Psychedelic Patent Troll?

Is MagicMed Industries Inc. the first patent troll to enter the psychedelic space? Or has MagicMed come up with a brilliant plan that will benefit the entire psychedelics industry by …

Business / Mushrooms / Patents / Psilocybin

Aion Therapeutics Files Five Patent Applications

In an September 3, 2020 press release on Psilocybin Alpha, Aion Therapeutics reported that it was “pleased to announce that the Company has filed five patent applications with the United …

Business / Patents / Psilocybin

5 Tips for Evaluating Psychedelic Patents

In previous articles, Psilocybin Technology wrote about the emerging psychedelics industry and its newfound focus on intellectual property. The recent and dramatic increase in patent filings gives rise to questions …

Aeruginascin / Molecules vs. Mushrooms / Mushrooms / Psilocybin / Psilocybin Chemistry / Psilocybin Derivatives / Wood Lover Paralysis

MAPS Speakers Discuss Importance Entourage Effect and “Minor” Tryptamines

Scientists at MAPS Webinar Series Discuss the Importance of “Minor” Tryptamines and the Entourage Effect Recently, several experts in psychedelic medicine have presented at MAPS webinar series hosted by Shannon …

Business / Mushrooms / Psilocybin

Patent Attorney Charles Boulakia joins Flourish Mushrooms

On February 4, 2020, the Yield Growth Corporation announced that Patent Lawyer, Charles Boulakia was appointed to the Flourish Mushroom Labs Advisory Board. According to the press release Mr. Boulakia …

Business / Psilocybin / Psilocybin Chemistry / Psilocybin Science

COMPASS Pathways’s Crystalline Form Patent

Recently, Compass Pathways issued a press release stating “that it has been granted US Patent No 10,519,175 (“the ‘175 patent”), relating to methods of treating drug-resistant depression with a psilocybin …

Business / Molecules vs. Mushrooms / Mushrooms / Psilocybin / Psilocybin Chemistry / Psilocybin Derivatives / Psilocybin Science / State of the Art

Psychedelic Investment Opportunities – 2020 Perspective

Investing in psychedelics (e.g., magic mushrooms, psilocybin, etc.) has became a hot topic during 2019.  Following Peter Thiel’s investment in Compass Pathway in 2018, several high-profile investors entered the psychedelic …

Business / Microdosing / Mushrooms / Psilocin / Psilocybin / Treatment

Has Yield Growth subsidiary Flourish Mushroom Labs revolutionized the field of psychedelics?

Yield Growth subsidiary Flourish Mushroom Labs appears to have discovered a fundamentally new use for the active compounds in magic mushrooms, i.e. psilocin and its prodrug psilocybin. On December 10, …

Posts navigation

Older posts

Recent Posts

  • Nova Mentis Launches Entourage Effect Research
  • Graham Pechenik and Noah Potter discuss Psychedelic Patents
  • MindMed – Two Steps Closer to Next Generation Magic Mushroom Formulations
  • COMPASS Pathways’ $100+ Million Crystalline Form Patent
  • MagicMed – The First Psychedelic Patent Troll?

Recent Comments

  • Psilocybin Expert on Taking Pure Psilocybin is Different from Eating Magic Mushrooms
  • jim on Cannabis and Magic Mushrooms – A Near Perfect Analogy
  • jeff on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • jeff on Chemical & Engineering News Discusses Entourage Effect
  • jeff on Psilocybin Clinical Trials Approved by FDA

Archives

  • January 2021
  • November 2020
  • September 2020
  • July 2020
  • February 2020
  • January 2020
  • December 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • Aeruginascin
  • Anxiety
  • Business
  • Cognitive Enhancement
  • Decriminalization
  • Depression
  • Law
  • Legalization
  • Mass
  • Microdosing
  • Molecules vs. Mushrooms
  • Mushrooms
  • Patents
  • Psilocin
  • Psilocybin
  • Psilocybin Chemistry
  • Psilocybin Derivatives
  • Psilocybin Science
  • Research
  • State of the Art
  • Treatment
  • Uncategorized
  • Unmet Need
  • Wood Lover Paralysis

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2021 Psilocybin Technology – OnePress theme by FameThemes